Baystreet Staff -

Airware Labs Hires Schultz Public Relations, LLC as Market Adoption Surges

[ACCESSWIRE]

Firm to Highlight Solutions to Health Challenges and Landmark Product Adoption 

SCOTTSDALE, AZ / ACCESSWIRE / January 14, 2015 / Airware Labs Corp. (OTCQB: AIRW), an innovator in pioneering breathing devices and skin care products that enhance the quality of life, personal health and well-being, today announced it has selected Schultz Public Relations, LLC as its public relations agency of record. The Washington, D.C. area firm will work with Airware Labs Corp. to build upon the company's reputation as a leader in the delivery of pioneering personal health products at a pivotal time in the company's revenue growth.

"We are experiencing record consumer demand for our products both domestically and internationally. At the same time, we are expanding our product lines and distribution agreements along with our patent portfolio. The timing of these significant advances couldn't be more beneficial to our supporters, investors and would-be investors given this momentous period when ongoing worldwide health challenges continue to dominate consumer interest and concern. We expect 2015 to be an exceptional year in the growth of our company, which is why we need to partner with Schultz Public Relations, LLC," said Jeffrey Rassas, CEO of Airware Labs Corp. "They have both the extensive experience and demonstrated knowledge to help us communicate through the diverse channels that will allow us to continue to enhance awareness of our existing and growing line of products."

The agency will manage strategic communications and media relations activities associated with the company's growing product line. "We look forward to partnering with Airware Labs Corp. at such an important time in the history of the company. Their dedication to pioneering health and quality of life products couldn't be more impressive," said Sharon Schultz, President, Schultz Public Relations, LLC. "We are excited at the prospect of building on their successes to continue to grow brand awareness, so everyone can have the opportunity to improve their personal health and quality of life."

About Airware Labs Corporation:

Airware Labs Corp. (publicly traded as OTCQB: AIRW) provides patented, innovative technology solutions for consumer products that promote better health and enhanced wellbeing. The company's products address important personal health and quality of life issues providing antibacterial and therapeutic defense against airborne bacteria, viruses, and allergens as well as congestion, snoring, insomnia, nausea, headaches, and an athletic performance enhancing breathing aid that increases oxygen to fuel cells in the body. In addition, the company has introduced a new line of skin care products. Airware Labs Corp. sells its products through partners including Wal-Mart, CVS, Walgreens, Albertsons, Drugstore.com, Acme, Shoppers, Shop n' Save, ACME, Farm Fresh as well as individuals in the United States, Canada, and Europe. The company is headquartered in Scottsdale, Arizona. Explore our extensive product line at http://www.airwarelabs.com and learn more about our company by visiting http://airwarelabscorp.com.

Forward-Looking Statement:

The statements in this press release regarding any implied or perceived benefits from the release by Airware Labs Corp. of its products are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

CONTACT:

Sharon Schultz
(301)-351-0109
[email protected]

Investor Relations:

Jeffrey Rassas
(480) 463-4246
Free: 877-876-4868
[email protected]
http://www.airwarelabs.com

 

SOURCE: Airware Lab Corp.